SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950005-03-000376
Filing Date
2003-03-21
Accepted
2003-03-21 16:37:54
Documents
4
Period of Report
2003-01-13

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT p16821_10k.txt 10-K 229589
3 EXCLUSIVE LICENSE AGREEMENT FOR TOSTREX(TM) p16821_ex10-10.txt EX-10.10 124825
4 SUBSIDIARIES OF CELLEGY PHARMACEUTICALS, INC. p16821_ex21-1.txt EX-21.1 272
5 CONSENT OF ERNST & YOUNG p16821_ex23-1.txt EX-23.1 982
  Complete submission text file 0000950005-03-000376.txt   357640
Mailing Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080 6506262200
CELLEGY PHARMACEUTICALS INC (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26372 | Film No.: 03612617
SIC: 2834 Pharmaceutical Preparations